Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35212753.
- Also identified by DOI 10.1001/jamanetworkopen.2022.0035 and PMC identifier 8881772.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cross-sectional study evaluates the representation of women as authors of pivotal trials of novel cardiovascular drugs approved by the US Food and Drug Administration between 2008 and 2020.
Medical subject headings
- Authorship
- Biomedical Research
- Cardiovascular Agents
- Clinical Trials as Topic
- Sex Distribution